Calendar Tonghua Dongbao Pharmaceutical Co., Ltd.

Equities

600867

CNE000000H87

End-of-day quote Shanghai S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
10.59 CNY +4.03% Intraday chart for Tonghua Dongbao Pharmaceutical Co., Ltd. +5.58% -2.22%

Chart calendar Tonghua Dongbao Pharmaceutical Co., Ltd.

85ee265cf357dd89e19944248d32e.vFhSdp0UdAX3pkP0JQqJxZmjHYcQ-t_SnmOUEG8e81g.7Q8qAPhGR1XG4Ru4dEG6q-vsLfFClr6m01HzQgBTyyiLIT01-kBBTpuTBg~8306446cb2e0725bf5186e1568dbfb18

Upcoming events on Tonghua Dongbao Pharmaceutical Co., Ltd.

20/08/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)
15/04/2025 Q4 2024 Earnings Release (Projected)
24/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Tonghua Dongbao Pharmaceutical Co., Ltd.

26/04/2024 Q1 2024 Earnings Release
19/04/2024 03:00 Annual General Meeting
28/03/2024 Q4 2023 Earnings Release
27/02/2024 02:00 Extraordinary Shareholders Meeting
30/10/2023 Q3 2023 Earnings Release
07/09/2023 03:00 Extraordinary Shareholders Meeting
21/08/2023 Q2 2023 Earnings Release
11/05/2023 03:00 Annual General Meeting
26/04/2023 Q1 2023 Earnings Release
20/04/2023 Q4 2022 Earnings Release
30/10/2022 Q3 2022 Earnings Release
15/09/2022 03:00 Extraordinary Shareholders Meeting
30/08/2022 Interim 2022 Earnings Release
10/05/2022 03:00 Annual General Meeting
28/04/2022 Q1 2022 Earnings Release
18/04/2022 FY 2021 Earnings Release
25/03/2022 02:00 Extraordinary Shareholders Meeting
09/12/2021 02:00 Extraordinary Shareholders Meeting
27/10/2021 Q3 2021 Earnings Release
25/08/2021 03:00 Extraordinary Shareholders Meeting

Past dividends on Tonghua Dongbao Pharmaceutical Co., Ltd.

08/06/2023 Final Payment 0.25 CNY
27/10/2022 Interim Payment 0.25 CNY
07/06/2022 Annual 0.3 CNY
30/05/2021 Annual 0.21 CNY
24/05/2020 Annual 0.2 CNY
22/05/2019 Annual 0.2 CNY
24/05/2018 Annual 0.2 CNY
05/06/2017 Annual 0.2 CNY
01/06/2016 Annual 0.2 CNY
17/05/2015 Annual 0.2 CNY

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CNY
Released
Forecast
Spread
2 777
2 921
-4.93%
2 892
3 021
-4.27%
3 268
3 277
-0.29%
2 778
2 949
-5.77%
3 075
3 009
2.2%

3 426

EBITDA
Million CNY
Released
Forecast
Spread
1 121
1 238
-9.5%
1 335
1 229
8.65%
1 693
1 422
19.05%
1 963
1 187
65.36%
0,00
1 429
-

1 663

EBIT
Million CNY
Released
Forecast
Spread
968
1 130
-14.38%
1 181
1 090
8.33%
1 549
1 418
9.23%
1 829
1 899
-3.67%
1 365
1 258
8.51%

1 501

Earnings before Tax (EBT)
Million CNY
Released
Forecast
Spread
952
1 121
-15.04%
1 108
1 085
2.16%
1 534
1 445
6.22%
1 830
1 895
-3.48%
1 366
1 272
7.39%

1 503

Net income
Million CNY
Released
Forecast
Spread
811
960
-15.53%
930
930
0.04%
1 308
1 217
7.48%
1 582
1 630
-2.94%
1 168
1 080
8.15%

1 299

EPS
CNY
Released
Forecast
Spread
0,40
0,47
-15.14%
0,46
0,46
0.89%
0,64
0,60
6.65%
0,79
0,81
-2.07%
0,59
0,54
9.26%

0,65

Announcement Date14/04/2014/01/2124/01/2206/02/2329/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million CNY
Released
Forecast
Spread
887
987
-10.12%
500
648
-22.88%
712
842
-15.51%
679
973
-30.15%
665
795
-16.27%
701
701
-0%
725
807
-10.17%
984
790
24.6%
591
873
-32.26%

751


875


855

EBIT
Million CNY
Released
Forecast
Spread
980
459
113.76%
403
137
195.32%
259
231
12.1%
186
291
-36.29%
290
276
4.77%
273
270
1.03%
317
283
11.8%
486
240
102.31%
239
359
-33.42%

292


354


362

Net income
Million CNY
Released
Forecast
Spread
























215
253
-15.15%









EPS
CNY
Released
Forecast
Spread
0,41
0,40
2.5%
0,18
0,06
200%
0,11
0,10
10%
0,09
0,11
-18.18%
0,13
0,12
8.33%
0,11
0,12
-8.33%
0,14
0,12
16.67%
0,21
0,11
90.91%
0,11
0,15
-26.67%

0,15


0,16


0,18

Announcement Date28/04/2230/08/2230/10/2206/02/2326/04/2321/08/2330/10/2329/01/2427/04/24---

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600867 Stock
  4. Calendar Tonghua Dongbao Pharmaceutical Co., Ltd.